Deferred Tax Assets, Valuation Allowance in USD of HELIUS MEDICAL TECHNOLOGIES, INC. from Q1 2016 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
HELIUS MEDICAL TECHNOLOGIES, INC. quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q1 2016 to Q4 2024.
  • HELIUS MEDICAL TECHNOLOGIES, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $41.1M, a 9.33% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

HELIUS MEDICAL TECHNOLOGIES, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $41.1M +$3.5M +9.33% 31 Dec 2024 10-K 25 Mar 2025
Q4 2023 $37.6M +$3.81M +11.3% 31 Dec 2023 10-K 25 Mar 2025
Q4 2022 $33.8M +$2.55M +8.16% 31 Dec 2022 10-K 28 Mar 2024
Q4 2021 $31.2M +$3.05M +10.8% 31 Dec 2021 10-K 09 Mar 2023
Q4 2020 $28.2M +$3.39M +13.7% 31 Dec 2020 10-K 14 Mar 2022
Q4 2019 $24.8M +$6.01M +32% 31 Dec 2019 10-K 10 Mar 2021
Q4 2018 $18.8M +$4.21M +28.9% 31 Dec 2018 10-K 12 Mar 2020
Q4 2017 $14.6M +$4.35M +42.5% 31 Dec 2017 10-K 14 Mar 2019
Q4 2016 $10.2M 31 Dec 2016 10-K 12 Mar 2018
Q1 2016 $7.25M 31 Mar 2016 10-KT 03 Apr 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.